How to buy Galmed Pharmaceuticals stock

Fact checked

Galmed Pharmaceuticals is a biotechnology business based in the US. Galmed Pharmaceuticals stocks (GLMD.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.93 – an increase of 9.52% over the previous week. Galmed Pharmaceuticals employs 19 staff and has a market cap (total outstanding stock value) of $12.1 million.

How to buy stocks in Galmed Pharmaceuticals

Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
Open your brokerage account. Complete an application with your details.
Confirm your payment details. Fund your account.
Research the stock. Find the stock by name or ticker symbol – GLMD – and research it before deciding if it's a good investment for you.
Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
Check in on your investment. Optimize your portfolio by tracking your stock.

Finder's Pick for

Beginners

CIBC Investor's Edge

Finder's Pick for

Global Trading

Interactive Brokers

Finder's Pick for

Commodity Stocks

Scotia iTRADE

Finder's Pick for

Free Trades

Wealthsimple Trade

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. You can learn more about our methodology here. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

Our pick for beginners. We chose CIBC Investor's Edge for this category because it offers low and competitive fees, as well as an easy-to-use, user-friendly interface and provides a number of learning resources to help you get acquainted with the platform. In addition, students can take advantage of special pricing for making trades if they have a CIBC Student Bank account.
Our pick for global trading. We chose Interactive Brokers for this category because it offers extensive trading capabilities and access to advanced trading tools to help traders in their investing journey, as well as access to a large number of international stock exchanges.
Our pick for commodity stocks. We chose Scotia iTRADE for this category because it offers an easy-to-use, user-friendly UX and provides access to a variety of learning resources to help you get acquainted with trading and how the platform works.
Our pick for free trades. We chose Wealthsimple Trade for this category because it offers commission-free trading. With no account fee, the mobile app is clean and intuitive to use.

What's in this guide?

Can I buy shares in Galmed Pharmaceuticals?
Has coronavirus impacted Galmed Pharmaceuticals shares?
Galmed Pharmaceuticals shares summary
Compare share dealing platforms
Is Galmed Pharmaceuticals stock a buy or sell?
Galmed Pharmaceuticals performance over time
Galmed Pharmaceuticals's financials
How volatile are Galmed Pharmaceuticals shares?
Does Galmed Pharmaceuticals pay a dividend?
Other common questions

Galmed Pharmaceuticals stock price (NASDAQ:GLMD)

Use our graph to track the performance of GLMD stocks over time.

Galmed Pharmaceuticals shares at a glance

Key figures

Information last updated 2022-06-25.

Latest market close	$0.48
52-week range	$0.42 - $3.42
50-day moving average	$0.82
200-day moving average	$1.80
Wall St. target price	$4.13
PE ratio	N/A
Dividend yield	$0 (0%)
Earnings per share (TTM)	$-1.19

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6

Name	Product	Finder Rating	Stock Trading Fee	Account Fee	Available Asset Types	Offer
OFFER CIBC Investor's Edge CIBC Investor's Edge	OFFER	Finder Rating: ★★★★★ 4 / 5	$4.95–$6.95	$0 if conditions met, otherwise $100 a year	Stocks, Bonds, Options, Mutual Funds, ETFs	Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.	Go to site View details	Compare	loading Fetching your data...
Interactive Brokers Interactive Brokers		Finder Rating: ★★★★★ 4.1 / 5	Min. $1.00, Max. 0.5%	$0	Stocks, Bonds, Options, ETFs, Currencies, Futures		Go to site View details	Compare	loading Fetching your data...
Scotia iTRADE Scotia iTRADE		Finder Rating: ★★★★★ 3.8 / 5	$4.99–$9.99	$0	Bonds, Options, Mutual Funds, ETFs, GICs, International Equities		Go to site View details	Compare	loading Fetching your data...
FREE TRADES Wealthsimple Trade Wealthsimple Trade	FREE TRADES	Finder Rating: ★★★★★ 3.9 / 5	$0	$0	Stocks, ETFs	Get $25 when you open a Wealthsimple Trade account and fund at least $150.	Go to site View details	Compare	loading Fetching your data...
Questrade Questrade		Finder Rating: ★★★★★ 4.2 / 5	$4.95 - $9.95	$0	Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals	Get $50 in free trades when you fund your account with a minimum of $1,000.	Go to site View details	Compare	loading Fetching your data...
OFFER Qtrade Direct Investing Qtrade Direct Investing	OFFER	Finder Rating: ★★★★★ 4.1 / 5	$6.95 - $8.75	$0 if conditions met, otherwise $25/quarter	Stocks, Bonds, Options, Mutual Funds, ETFs, GICs	Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.	Go to site View details	Compare	loading Fetching your data...

Compare up to 4 providers

Online stock trading

Is it a good time to buy Galmed Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Galmed Pharmaceuticals price performance over time

Historical closes compared with the close of $0.483 from 2022-06-24

1 week (2022-06-17)	9.52%
1 month (2022-05-26)	-8.00%
3 months (2022-03-25)	-68.22%
6 months (2021-12-23)	-76.21%

1 year (2021-06-25)	-84.62%
2 years (2020-06-26)	-90.34%
3 years (2019-06-26)	6.46
5 years (2017-06-26)	6.02

Galmed Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	-41.18%
Return on equity TTM	-76.83%
Profit margin	0%
Book value	$0.97
Market capitalisation	$12.1 million

TTM: trailing 12 months

Galmed Pharmaceuticals share dividends

We're not expecting Galmed Pharmaceuticals to pay a dividend over the next 12 months.

Galmed Pharmaceuticals share price volatility

Over the last 12 months, Galmed Pharmaceuticals's shares have ranged in value from as little as $0.417 up to $3.42. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Galmed Pharmaceuticals's is 1.8253. This would suggest that Galmed Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Galmed Pharmaceuticals overview

Galmed Pharmaceuticals Ltd. , a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a research agreement with Gannex Pharma Co. , Ltd.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

How to buy Galmed Pharmaceuticals (GLMD) stocks

Learn how to easily invest in Galmed Pharmaceuticals stocks.